Perrigo Company plc , today announced that it has reached a definitive agreement to sell its Animal Health business to PetIQ in a transaction valued at $185 million in cash. This transaction is consistent with Perrigo's plans to transform itself into a consumer-focused, self-care company.
Perrigo CEO and President Murray S. Kessler commented, "We are pleased to have reached an agreement with PetIQ on selling our Animal Health business and look forward to working with them to ensure a seamless transition. This divestiture helps us focus our portfolio on the consumer self-care market. In PetIQ's hands, we have no doubt the Animal Health business will be in a strong position to execute on its strategy."
In calendar year 2018, Perrigo realized $94 million in net sales and $0.08 of adjusted diluted EPS from the Animal Health business. The transaction is subject to customary closing conditions. William Blair is serving as exclusive financial advisor to Perrigo on the transaction. Morgan, Lewis and Bockius is serving as Perrigo's legal counsel.
Perrigo Company plc 今日宣布，已达成最终协议，将其动物健康业务出售给 PetIQ ，交易金额为1.85亿美元现金。这笔交易符合 Perrigo 转型为以消费者为中心的自我保健公司的计划。
Perrigo 首席执行官兼总裁 Murray S.Kessler 评论道：“我们很高兴与 PetIQ 就销售我们的动物健康业务达成协议，并期待与他们合作，确保无缝过渡。这种资产剥离有助于我们将我们的投资组合集中在消费者自我保健市场上。在 PetIQ 的手中，毫无疑问，动物健康业务将在其战略执行上处于有利地位。”
在2018财年， Perrigo 实现了9,400万美元的净销售额和0.08美元的经调整的动物健康业务摊薄每股收益。交易须遵守惯例成交条件。William Blair 是 Perrigo 的独家财务顾问。摩根、刘易斯和博克斯是佩里戈的法律顾问。